Locations:
Search IconSearch

Neurosciences

22-NEU-2832861-epilepsy-evaluation-in-infant-650×450
April 6, 2022/Genomic Medicine

Prediction Model Aids in the Early Diagnosis of Dravet Syndrome

Integrates genetic and clinical data to distinguish from GEFS+ and milder epilepsies

22-NEU-2711969-epilepsy-surgery_650x450
April 4, 2022/Neurosciences/Podcast

Epilepsy Surgery: An Underused Treatment Option (Podcast)

Surgery can be a game changer when medications fail to control seizures

22-NEU-2826663_multiple-sclerosis-650×450

Pair of NIH Grants to Probe Multiple Sclerosis Pathogenesis on Two Fronts

Assessing the role of circadian disruption, characterizing patterns of thalamic atrophy

22-NEU-2763209-CQD-Hero-650×450

Closing Racial Gaps in Cerebrovascular Mortality

Minority Stroke Program addresses racial disparities pinpointed in a recent study

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

22-NEU-2768409_neuropsych-treatment_650x450

Neuropsychiatric Management of the ICU Survivor

Guidance for treatment, including the role of post-ICU recovery clinics

Medications in the ICU. Medicinal lines next to patient bed

Neuropsychiatric Assessment of the ICU Survivor

Guidance for recognizing and screening for post-intensive care syndrome

22-NEU-2678473-CQD-Hero-650×450
March 22, 2022/Neurosciences/PM&R

Medical Management of Gait Impairment in Multiple Sclerosis: Time to Mind the Data Gaps

More evidence needed on pharmacologic therapy alone and combined with gait training

22-NEU-2763210-CQD-Hero-650×450
March 21, 2022/COVID-19

Cerebrovascular Injury From ARDS: Is It More Common in the Setting of COVID-19?

Comparative MRI study suggests unique pathophysiology in COVID-19 context

22-NEU-2806208 dementia_650x450
March 18, 2022/Behavioral Health

Initial Cognitive Manifestation of Dementia Predicts Later Behavioral Symptoms

Risk of agitation, delusions, personality change and more is shaped by early presentation

22-NEU-2798010-CQD-Hero-650×450

Three Standout Investigations at ACTRIMS 2022

Research avenues to keep an eye on in MS and NMOSD diagnostics and therapeutics

BackPage 22 of 113Next

Advertisement

Ad